Multiplex solution genotyping without probes of the factor V Leiden (G1691A), Prothrombin (G20210A), and MTHFR (C677T and A1298C) mutations in one tube by single color high-resolution melting analysis [abstract] by Seipp, Michael
MULTIPLEX SOLUTION GENOTYPING WITHOUT PROBES OF THE 
FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A), AND MTHFR 
(C677T AND A1298C) MUTATIONS IN ONE TUBE BY SINGLE COLOR 
HIGH-RESOLUTION MELTING ANALYSIS. 
 
Michael Seipp1, Jamie Williams2, Cindy Meadows2 and Carl Wittwer1,2,3 
 
1ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake 
City, UT 84108; 2ARUP Laboratories, Inc, 500 Chipeta Way, Salt Lake City, UT 84108; 
3Department of Pathology, University of Utah, Salt Lake City, UT 84112 
 
Background: Venous and arterial thrombotic diseases are serious health concerns with 
well established links to the Factor V Leiden (G1691A), Prothrombin (G20210A), 
MTHFR (C677T) and MTHFR (A1298C) mutations. The likelihood of developing 
disease is increased with the presence of mutations in multiple clotting factor genes.   
Methods: Four amplicons with non-overlapping melting temperature windows were 
created by varying the amplicon lengths from 40 base pairs to 120 base pairs and by 
using primers with G/C rich tails. Genotyping of each locus in the same closed-tube was 
based on the shape and position of the high-resolution melting transition. Heteroduplex 
melting analysis with LCGreen eliminated any need for probes. 
Results: The Tm windows for each gene were separated by at least 1°C with the wild 
type melting temperatures of 76.0°C for Factor V Leiden, 88.5°C for Prothrombin, 
84.5°C for MTHFR C677, and 80.5°C for MTHFR A1298. Within each window, the 
wild type, mutant, and heterozygous genotypes for each mutation, were resolvable. 
Concordant results between conventional LightCycler analysis and high-resolution 
melting were obtained on 120 blinded clinical samples. 
Conclusions: Genotyping by amplicon melting is a rapid, closed-tube method for 
genotyping without probes that can be multiplexed. The method was successfully 
applied to the four most common clotting factor mutations in a single tube.  The 
simplicity of the method allows rapid development of low-cost assays and does not 
require any arrays or complex instrumentation. 
